vendredi 21 octobre 2016

Onco Actu du 21 octobre 2016


1. Biologie

Science Snaps: leukaemia cells are born to run [Cancer Research UK]

Tumour cells may ‘hijack’ white blood cells to help spread [Cancer Research UK]

Metabolomics Study Reveals another Energy Source for Cancer Cells [NCI]

3.5 Prévention - UV

Doctors think you don’t use enough sunscreen [Reuters]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

NICE recommends wider use of tests to detect cancer-causing genetic condition [NICE]

Illumina, Genentech and BIO Weigh in on FDA Draft Guidance on Companion Diagnostics [RAPS]


5. Traitements

This New Nanotechnology Could Become the Next Major Cancer Breakthrough [Fortune]

5.10 Traitements - Essais

Assess institutional review boards by their quality of decisions, not ownership [STAT]

5.12 Immunothérapies

Seeing past cancer’s invisibility cloak [Cancer Research UK]

A New Immunotherapy Option for Treating Lung Cancer [AACR]

5.12.1 Immunothérapies - partenariats

Merck, Pfizer link with Debiopharm to test immunotherapy combo [PharmaTimes]

5.2 Pharma

ARIAD Reaffirms Commitment to Discovering and Developing Treatments for Patients with Rare Cancers [Ariad]

Roche highlights I/O combos, as it drops solo development of vanucizumab [FierceBiotech]

Roche bid for Avastin follow-on suffers blow with trial failure [Reuters]

5.3 Traitements - FDA, EMA, NICE...

AllTrials welcomes EMA’s transparency drive as it posts first set of CSRs [FierceBiotech]

FDA official warns other drug makers not to copy Sarepta [STAT]

EMA Transparency: New Clinical Reports Go Live [RAPS]

Opening up clinical data on new medicines [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

Eli Lilly Wins FDA Nod for New Soft Tissue Sarcoma Drug [Xconomy]

New treatment recommended for kidney cancer [NICE]

5.4 Traitements - Economie

Op-Ed: Our View on Value Frameworks in Oncology: Proposing Principles for Value Framework Development [OBR]

Oncologists knock ICER's lung cancer cost-effectiveness review [FiercePharma]

Defining the True Value of Innovation in Cancer Treatment [BMS]

Sanders seeks Ariad data on cancer drug price hikes [STAT]

Bernie Sanders, U.S. Rep Cummings seek info on Ariad leukemia drug [Reuters]

6. Lutte contre les cancers

AACR Issues Call for New SU2C Dream Team to Launch Attack on Colorectal Cancer [AACR]

6.10.1 Politiques (USA)

The Cancer Moonshot, Hereditary Cancers and Population Genetic Screening [CDC Genomics and Health Impact Blog]


6.11 Patients

'I sold my house to fund cancer treatment in Germany' [BBC News]

6.7 DMP, Big Data & applis

Automating big-data analysis [MIT News]

CancerLinQ™ Platform Hits Milestone of Having More than One Million Patient Records in System [ASCO]


6.8 Communication

How a cancer group thwarted Facebook's censorship: square breasts [The Guardian]